Who owns ADICET BIO ORD?
- Ticker: ACET
- CUSIP Number: 007002207
Tip: Access positions for across all investors
Analyze quarterly positions in Adicet Bio Ord with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Adicet Bio Ord stock
Who bought or sold ADICET BIO ORD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RA Capital Management | 933k | $8.1M | -21% | Jun 2026 |
|
| OrbiMed Advisors | 845k | $7.3M | -18% | Jun 2026 |
|
| Franklin Resources | 627k | $5.4M | 0% | Jun 2026 |
|
| Citadel Advisors | 466k | $4.0M | 22% | Jun 2026 |
|
| Vanguard Capital Management | 343k | $3.0M | 2% | Jun 2026 |
|
| Adage Capital Partners GP | 274k | $2.4M | 0% | Jun 2026 |
|
| Renaissance Technologies | 266k | $2.3M | 14% | Jun 2026 |
|
| Stonepine Capital Management | 246k | $2.1M | 11% | Jun 2026 |
|
| Alyeska Investment Group | 204k | $1.8M | 0% | Jun 2026 |
|
| Schonfeld Strategic Advisors | 196k | $1.7M | 100% | Jun 2026 |
|
| Carlyle | 184k | $1.6M | 0% | Jun 2026 |
|
| Acadian Asset Management | 125k | $1.1M | 6% | Jun 2026 |
|
| Two Sigma Investments | 97k | $837k | 125% | Jun 2026 |
|
| Geode Capital Management | 96k | $827k | -5% | Jun 2026 |
|
| DAFNA Capital Management | 94k | $811k | 0% | Jun 2026 |
|
| Bridgeway Capital Management | 86k | $743k | 100% | Jun 2026 |
|
| Marshall Wace | 80k | $687k | 100% | Jun 2026 |
|
| Trexquant Investment | 78k | $674k | 79% | Jun 2026 |
|
| Jane Street | 71k | $610k | 90% | Jun 2026 |
|
| Burkehill Global Management | 63k | $540k | 0% | Jun 2026 |
|
| BlackRock | 62k | $537k | 70% | Jun 2026 |
|
| Regeneron Pharmaceuticals | 61k | $523k | 100% | Jun 2026 |
|
| Rangeley Capital | 51k | $440k | -9% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 51k | $438k | 1% | Jun 2026 |
|
| Susquehanna International | 40k | $348k | -24% | Jun 2026 |
|
| Rbf Capital | 39k | $333k | 0% | Jun 2026 |
|
| State Street Corporation | 36k | $247k | 40% | Mar 2026 |
|
| Quadrature Capital | 36k | $313k | 100% | Jun 2026 |
|
| Dimensional Fund Advisors | 32k | $273k | 193% | Jun 2026 |
|
| UBS Group | 30k | $258k | -22% | Jun 2026 |
|
| Verdad Advisers | 25k | $218k | 100% | Jun 2026 |
|
| XTX Topco | 24k | $210k | 27% | Jun 2026 |
|
| Johnson & Johnson | 23k | $197k | 0% | Jun 2026 |
|
| Springbok Capital Management | 19k | $160k | 100% | Jun 2026 |
|
| Northern Trust | 18k | $159k | -4% | Jun 2026 |
|
| Occudo Quantitative Strategies | 17k | $144k | 10% | Jun 2026 |
|
| Squarepoint Ops | 15k | $132k | 100% | Jun 2026 |
|
| Vontobel Holding | 14k | $119k | -3% | Jun 2026 |
|
| Axq Capital | 11k | $95k | 100% | Jun 2026 |
|
| Jump Financial | 11k | $95k | 100% | Jun 2026 |
|
| SRS Capital Advisors | 6.0k | $52k | 100% | Jun 2026 |
|
| Vanguard Global Advisers | 5.2k | $45k | 0% | Jun 2026 |
|
| Simplex Trading | 4.8k | $42k | 246% | Jun 2026 |
|
| Morgan Stanley | 3.5k | $24k | 15% | Mar 2026 |
|
| Royal Bank of Canada | 1.7k | $15k | 0% | Jun 2026 |
|
| Tower Research Capital | 277.00 | $2.4k | -81% | Jun 2026 |
|
| Efficient Wealth Management | 246.00 | $2.0k | 0% | Jun 2026 |
|
| Jpmorgan Chase & Co | 196.00 | $1.7k | 100% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 50.00 | $432.000000 | 0% | Jun 2026 |
|
| Caitong International Asset Management | 47.00 | $406.000100 | 1467% | Jun 2026 |
|
| SBI Securities | 24.00 | $207.000000 | 26% | Jun 2026 |
|
| National Bank Of Canada /fi/ | 17.00 | $145.999400 | 0% | Jun 2026 |
|
| FMR | 6.00 | $52.000200 | 100% | Jun 2026 |
|
| TD Waterhouse Canada | 3.00 | $26.000100 | 100% | Jun 2026 |
|
| Danske Bank A/s | 1.00 | $9.000000 | 0% | Jun 2026 |
|
Who sold out of Adicet Bio Ord?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Woodline Partners | Mar 2026 | 313k | $2.1M |
| Prosight Management | Mar 2026 | 250k | $1.7M |
| ADAR1 Capital Management | Mar 2026 | 54k | $367k |
| Barclays | Mar 2026 | 25k | $170k |
| Goss Wealth Management | Mar 2026 | 3.9k | $26k |
| FNY Investment Advisers | Mar 2026 | 3.2k | $21k |